Furthermore, Kaplan‐Meier survival analysis showed that high TMEM52B expression correlated negatively with survival in NPC patients (Figure 1G), and Cox regression analysis indicated that TMEM52B expression was an independent risk factor for survival (Table1). This evidence concerns the gene TMEM52B and nasopharyngeal carcinoma.